Kroeger, N, Sanz, J, Stelljes, M, Martino, R, Rambaldi, A, Kwon, M, Sanchez-Guijo, F, Markova, M, Bondarenko, S, Eder, M, Heuser, M, Solano, C, Bonifazi, F, Wohlfarth, P, Massoud, R, Ayuk, F, Clausen, J, Choi, G, Greinix, H, Chiusolo, P, Patriarca, F, Gagelmann, N, Busca, A, Bug, G, Schroeder, T, Bethge, W, Glöckner, A, Hoelzer, D, Zey, S, Buchner, H, Wolschke, C. Matched unrelated vs. Haploidentical donor for allogeneic stem cell transplantation in patients with acute leukemia with identical GvHD prophylaxis-a randomized prospective european trial. BLOOD. 2025; 146DOI:10.1182/blood-2025-171. PMID:. IF:23.100(Q1/1D).

Westin, J, Chavez, J, Schuster, SJ, Vucinic, V, Young, PA, Johnson, PC, Bramanti, S, Rambaldi, A, Meijide, JB, Kato, K, Sancho, JM, Kwon, M, Solano, C, Fleming, S, Dahiya, S, Garcia-Sancho, AM, Ramos, PM, Pearson, D, Diallo, S, Zia, A, Segura, E, Masood, A, Barba, P. Rapcabtagene autoleucel (YTB323) for patients with first line high-risk large B-cell lymphoma: Phase II interim results. BLOOD. 2025; 146DOI:10.1182/blood-2025-670. PMID:. IF:23.100(Q1/1D).

Barba, P, Rambaldi, A, Boissel, N, Doki, N, Blaise, D, Ciceri, F, Meijide, JB, Kwon, M, Fleming, S, Goñi, CB, Teshima, T, Kato, K, Balsat, M, Jaeger, U, Shune, L, Ramos, PM, Pearson, D, Corcoran, J, Zia, A, Foster, M, Masood, A, Dickinson, M. Phase 1 evaluation of the safety and efficacy of rapcabtagene autoleucel (YTB323) in adult patients with Relapsed/Refractory B-cell acute lymphoblastic leukemia (r/r B-ALL). BLOOD. 2025; 146DOI:10.1182/blood-2025-811. PMID:. IF:23.100(Q1/1D).

Hinson, SR, Gupta, P, Paramasivan, NK, Dyck, PJB, Lennon, VA, Lachance, DH, Knight, AM, Rezk, M, Karsten, C, LaFrance-Corey, RG, Staff, NP, Hrstka, SC, Wu, JC, Klein, CJ, Zekeridou, A, Mckeon, A, Pittock, SJ, Lleixà, C, Querol, L, Dasari, S, Mills, JR, Dubey, D. Neural synaptic vesicle autoimmunity following aerosolized porcine neural tissue exposure: insights into autoimmune inflammatory polyradiculoneuropathy. EBioMedicine. 2025; 122DOI:10.1016/j.ebiom.2025.106053. PMID:41337934. IF:10.800(Q1/1D).

Alberti, P, Querol, L. Peripheral Nerve Society Training Grant Program: An Exciting Opportunity Not to Be Missed. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2025; 30(4)DOI:10.1111/jns.70076. PMID:41236205. IF:3.200(Q2/4D).

Armangué, T, Gómez-Ballesteros, R, Querol, L, Gutiérrez-Gutiérrez, G, Sotoca, J, Luque, AA, Villaverde, R, Reyes, V, Salas, E, Diaz, P, Maurino, J, Cortés-Vicente, E. ORGANIZATIONAL SUPPORT IN ADOPTING NEW TREATMENTS FOR GENERALIZED MYASTHENIA GRAVIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).

Chavarría-Elizondo, P, Tortella-Feliu, M, Fortea, L, De la Peña-arteaga, V, Juaneda-Seguí, A, Martínez-Zalacaín, I, Vilajosana, E, Radua, J, Shackman, AJ, Soriano-Mas, C, Fullana, MA. Combining Life History Calendars and Ecological Momentary Assessment for Evaluating Everyday Stress and Its Impact on Mental Health in Healthy Adults: Longitudinal Study. STRESS AND HEALTH. 2025; 41(6)DOI:10.1002/smi.70128. PMID:41307189. IF:2.700(Q2/4D).

Andersen, OM, de Waal, MWJ, Monti, G, Tesi, N, Jensen, AMG, De Geus, C, van Spaendonk, R, Vogel, M, Ahmad, S, Amin, N, Amouyel, P, Beecham, GW, Bellenguez, C, Berr, C, Bis, JC, Boland, A, Bossù, P, Bouwman, F, Bras, J, Charbonnier, C, Clarimon, J, Cruchaga, C, Daniele, A, Dartigues, JF, Debette, S, Deleuze, JF, Denning, N, Destefano, AL, Dols-Icardo, O, van Duijn, CM, Farrer, LA, Fernández, MV, van der Flier, WM, Fox, NC, Galimberti, D, Genin, E, Gille, JJP, Grenier-Boley, B, Grozeva, D, Guen, YL, Guerreiro, R, Haines, JL, Holmes, C, Hummerich, H, Ikram, MA, Ikram, MK, Kawalia, A, Kraaij, R, Lambert, JC, Lathrop, M, Lemstra, AW, Lleo, A, Myers, RM, Mannens, MMAM, Marshall, R, Martin, ER, Masullo, C, Mayeux, R, Mead, S, Mecocci, P, Meggy, A, Mol, MO, Nacmias, B, Naj, AC, Napolioni, V, Cochran, JN, Nicolas, G, Pasquier, F, Pastor, P, Pericak-Vance, MA, Pijnenburg, YAL, Piras, F, Quenez, O, Ramirez, A, Raybould, R, Redon, R, Reinders, MJT, Richard, AC, Riedel-Heller, SG, Rivadeneira, F, van Rooij, JGJ, Rousseau, S, Ryan, NS, Sanchez-Juan, P, Schellenberg, GD, Scheltens, P, Schott, JM, Seshadri, S, Sie, D, Sims, R, Sistermans, EA, Sorbi, S, van Swieten, JC, Tijms, B, Uitterlinden, AG, Visser, PJ, Wagner, M, Wallon, D, Wang, LS, Williams, J, Yokoyama, JS, Zarea, A, van der Lee, SJ, Olsen, JG, Hulsman, M, Holstege, H. Domain mapping of disease mutations reveals pathogenic SORL1 variants in Alzheimer's disease. Molecular Neurodegeneration. 2025; 20(1)DOI:10.1186/s13024-025-00907-z. PMID:41327266. IF:17.500(Q1/1D).

Mazurek, MH, Bassa, MJ, Padayachy, L, Wetzel, EA, Moiyadi, A, Perin, A, De Quintana, C, Prada, F, Nahed, B, DiMeco, F, Unsgard, G. An International Course on Intraoperative Ultrasound in Neurosurgery: Evaluation of a Multicenter, Hands-On Course in Promoting Familiarity and Use of Intraoperative Ultrasound in Neurosurgery. World Neurosurgery. 2025; 204DOI:10.1016/j.wneu.2025.124524. PMID:41033596. IF:2.100(Q2/4D).

Kallish, S, Camporeale, A, Hopkin, RJ, Jovanovic, A, Nordbeck, P, Veleva-Rotse, BO, Krusinska, E, Torra, R. Long-term efficacy of migalastat in females with Fabry disease. JOURNAL OF MEDICAL GENETICS. 2025; 62(12)DOI:10.1136/jmg-2024-110596. PMID:40897525. IF:3.700(Q2/3D).

Vespalcova, H, Knox, B, Sakhi, AK, Thomsen, C, Aguilar-Lacasana, S, Cosin-Tomas, M, Gomez-Herrera, L, Garcia, OS, Llurba, E, Gomez-Roig, MD, Sunyer, J, Dadvand, P, Bustamante, M, Vrijheid, M. Association of in utero exposure to phthalate and DINCH metabolites with placental DNA methylation. ENVIRONMENT INTERNATIONAL. 2025; 206DOI:10.1016/j.envint.2025.109946. PMID:41275763. IF:9.700(Q1/1D).

Rolland, M, Bustamante, M, Jedynak, P, Thomsen, C, Sakhi, AK, Foraster, M, Gascon, M, Gómez-Roig, MD, Llurba, E, Rivas, I, Ouellet-Morin, I, Ferrer, M, Morillas, A, Carras, S, Bayat, S, Lyon-Caen, S, Pozo, OJ, Vrijheid, M, Sunyer, J, Slama, R, Dadvand, P, Philippat, C. Prenatal phenol exposure and child behaviour: insights into the hypothalamic-pituitary-adrenal axis from two prospective mother-child cohorts. Lancet Planetary Health. 2025; 9(12)DOI:10.1016/j.lanplh.2025.101330. PMID:41386271. IF:21.600(Q1/1D).

Miravitlles, M, Calle, M, Molina, J, Almagro, P, Gomez, JT, Trigueros, JA, Sánchez-Angarita, E, Cosio, BG, Casanova, C, López-Campos, JL, Riesco, JA, Simonet, P, Rigau, D, Iskakova, A, Sanz, MP, Sobradillo, P, Alcázar-Navarrete, B, Garin, N, Soler-Cataluña, JJ. Update 2025 of the Spanish COPD Guidelines (GesEPOC): Pharmacological Treatment of Stable COPD. ARCHIVOS DE BRONCONEUMOLOGIA. 2025; 61(12)DOI:10.1016/j.arbres.2025.10.008. PMID:41198528. IF:9.200(Q1/1D).

Meza, N, Madrid, E, Urrútia, G, Clarke, M. Aligning research funding and the production of useful evidence to reduce research waste. Bmj Evidence-Based Medicine. 2025; 30(6)DOI:10.1136/bmjebm-2025-114324. PMID:41326283. IF:7.600(Q1/1D).

Grau-Pérez, M, Ciudad, C, Molina-Leyva, A, Martorell, A, Vilarrasa, E, Albert, I, Garcias-Ladaria, J, Melgosa, FJ, Rivera, R, Campos, M, Haselgruber, S, Ochando, G, Pascual, JC, García-Ruiz, R, Alfageme, F. ADOLESBIO-HS: A Real-World Multicenter Case Series on the Effectiveness and Safety of Adalimumab in Adolescents with Moderate-to-Severe Hidradenitis Suppurativa. DERMATOLOGY. 2025; 241(5-6)DOI:10.1159/000546647. PMID:40587963. IF:2.700(Q2/4D).

Ferrer, AL, Belinchón, I, Serra, MC, Clua, MG, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. REVIEW OF PATIENT DECISION AIDS FOR PSORIASIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).

Ferrer, AL, Belinchón, I, Serra, MC, Martínez, LE, Mate, AR, Suárez, BP, Alarcón, SS, de la Cueva, P. UNDERSTANDING PATIENT PRIORITIES IN PSORIASIS TREATMENT: A REVIEW OF KEY DECISION-MAKING DRIVERS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).

Strober, B, Puig, L, Lebwohl, MG, Lakshminarasimhan, B, Khan, SA, Pillai, N, Kappelhoff, B, Weatherill, A, Warren, RB. HIGHER MORTALITY FOR GENERALIZED PUSTULAR PSORIASIS COMPARED WITH PLAQUE PSORIASIS HIGHLIGHTS THE NEED FOR IMPROVED TREATMENTS: INSIGHTS FROM A META-ANALYSIS. VALUE IN HEALTH. 2025; 28(12)DOI:. PMID:. IF:6.000(Q1/1D).

Li, R, Hensley, PJ, Babjuk, M, Bukavina, L, Psutka, SP, Lerner, SP, O'Donnell, MA, Lotan, Y, Bree, KK, Redorta, JP, McConkey, DJ, Lee, BH, Mariappan, P, Mertens, LS, Soloway, MS, Svatek, RS, Tan, WS, Williams, SB, Gupta, S, Buckley, R, Kamat, AM. Intermediate-risk Non-muscle-invasive Bladder Cancer: Recommendations for Definitions, Risk Stratification, Management Strategies, and Clinical Trial Design from the International Bladder Cancer Group. European Urology Oncology. 2025; 8(6)DOI:10.1016/j.euo.2025.08.003. PMID:41076366. IF:9.300(Q1/1D).

Zamora, V, Garin, O, Suárez, JF, Guedea, F, Pont, A, Pardo, Y, Goñi, A, Mariño, A, Hervás, A, Herruzo, I, Cabrera, P, Sancho, G, León, JPD, Macías, V, Gutiérrez, C, Castells, M, Ferrer, M. Twenty-year Patient-reported Outcomes After Surgery, Radiotherapy, or Brachytherapy for Localized Prostate Cancer. European Urology Open Science. 2025; 82DOI:10.1016/j.euros.2025.10.007. PMID:41311640. IF:4.500(Q1/2D).